Delivery Order SPE2DB22D2006-SPE2DB25FW3LK
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $23,123.28 on August 7, 2025, for the supply of AVEED 750 mg/3 mL vials. This firm fixed-price delivery order, which has an ultimate completion date of August 28, 2025, represents a competitive award with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a delivery order valued at $14,452.05 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of AVEED 750 mg/3 mL vials. The contract represents a firm fixed price delivery order with an ultimate completion date of August 20, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's established capability to meet...
- The Defense Logistics Agency awarded a delivery order valued at $44,319.62 to AmerisourceBergen Drug Corp for AVEED 750 mg/3 mL vials on August 7, 2025, with completion targeted for August 28, 2025. This firm fixed-price delivery order, which was not set aside for small business, represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's distribution center in...
- The Defense Logistics Agency awarded a $14.5K delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of AVEED 750 mg/3 mL vials. The contract, which is non-set-aside and competitively awarded, carries a firm fixed price structure with an ultimate completion date of August 12, 2025. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,300.50 firm fixed-price delivery order is for the supply of AVEED 750 MG/3 ML VIAL 3ML, a specialty medication. The contract has an ultimate completion date of August 16, 2022 and was awarded on July 26, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,926.94 firm fixed-price delivery order is for the medical product "AVEED 750 MG/3 ML VIAL 3ML" and has an ultimate completion date of March 19, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of AVEED 750 MG/3 ML VIAL 3ML medical products. The contract has a ceiling value of $3,853.88 and a completion date of April 2, 2025. This is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide AVEED 750 MG/3 ML VIAL 3ML pharmaceutical products. The delivery order has a ceiling value of $3,882.60 and a completion date of April 26, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation indicated. This delivery order is issued under a larger...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of AVEED 750 MG/3 ML VIAL 3ML medical products. The $28,095.12 firm-fixed-price delivery order has an ultimate completion date of March 7, 2024. The contract is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with the DLA...
- This federal contract award, with a ceiling value of $48,173.50, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order, is for the supply of AVEED 750 MG/3 ML VIAL 3ML, a pharmaceutical product. The contract is not designated as a set-aside and has an ultimate completion date of February 26, 2025. Amerisourcebergen Drug Corp, the awardee,...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW3LKDelivery Order
The Defense Logistics Agency awarded a $34,684.92 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of AVEED 750 MG/3 ML vials. The contract is competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of September 5, 2025. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical support vehicle valued at $999,999,999 through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company maintains an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This specific delivery order for AVEED, a testosterone replacement therapy medication, reflects the company's ongoing role in supplying specialized pharmaceutical products to support Department of Defense healthcare requirements. The non-set-aside competitive award demonstrates AmerisourceBergen's established capability to meet federal procurement standards through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.7k | 8/14/25 |